Clinical Trials on Advanced Solid Tumors Harboring NTRK Fusion in Spain
Total 224 results
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more
-
BayerCompletedSolid Tumors Harboring NTRK FusionUnited States, Belgium, Italy, Germany, Australia, Spain, Singapore, Denmark, France, Ireland
-
BayerActive, not recruitingSolid Tumors Harboring NTRK FusionUnited States, China, Poland, Australia, Germany, Japan, Canada, Italy, Czechia, Spain, Turkey, United Kingdom, Sweden, Netherlands, France, Switzerland, Korea, Republic of, Denmark, Ireland, Israel, Ukraine
-
BayerActive, not recruitingSolid Tumors Harboring NTRK FusionUnited States, Korea, Republic of, China, Japan, India, France, Turkey, Portugal, Spain, Taiwan, Czechia, Sweden, Brazil, Denmark, Singapore, Argentina, Germany, Ireland
-
Merus N.V.RecruitingNSCLC Harboring NRG1 Fusion | Solid Tumours Harboring NRG1 Fusion | Pancreatic Cancer Harboring NRG1 Fusion | NRG1 FusionSpain, France, Israel, Belgium, Denmark, United States, Korea, Republic of, Japan, Germany, Netherlands, Austria, Canada, Italy, Norway, Singapore, Sweden, Taiwan, United Kingdom
-
PfizerCompletedSolid Tumors Harboring a BRAF V600 MutationUnited States, France, Italy, Singapore, Australia, Spain, Switzerland, Canada, Belgium
-
PharmaMarRecruitingAdvanced Solid TumorsSpain
-
Bristol-Myers SquibbWithdrawnAdvanced Solid TumorsSpain
-
Janssen Research & Development, LLCRecruitingAdvanced Stage Solid TumorsSpain
-
Debiopharm International SARecruitingAdvanced Solid TumorsNetherlands, Spain
-
AstraZenecaCompletedAdvanced Solid TumorsUnited States, Spain
-
PharmaMarCompletedADVANCED SOLID TUMORSUnited States, Spain
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
PharmaMarRecruitingPatients With Advanced Solid TumorsSpain
-
Turning Point Therapeutics, Inc.WithdrawnMetastatic Solid Tumor | Locally Advanced Solid TumorUnited States, Spain
-
PharmaMarCompletedSpecific Advanced Solid TumorsSpain, United Kingdom
-
PharmaMarRecruiting
-
Pierre Fabre MedicamentActive, not recruitingAdvanced or Metastatic Solid TumorsFrance, Spain
-
Taiho Oncology, Inc.TerminatedAdvanced Solid TumorsItaly, Spain, United States, Netherlands, United Kingdom
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
PharmaMarCompletedAdvanced Malignant Solid TumorsSpain, United States
-
SanofiCompletedAdvanced Solid TumorFrance, Spain
-
BeiGeneRecruitingAdvanced Solid TumorsUnited States, Australia, Spain
-
TOLREMO therapeutics AGRecruitingCancer | Adult Solid Tumor | Advanced Solid Tumor | Adult DiseaseSpain, Switzerland
-
Janssen Research & Development, LLCRecruitingAdvanced Solid TumorsUnited States, France, Spain
-
Debiopharm International SARecruitingAdvanced Solid TumorsSpain, United States, Switzerland
-
BeiGeneTerminatedAdvanced Solid TumorsAustralia, Spain, New Zealand
-
AstraZenecaParexelTerminatedAdvanced Solid TumoursUnited States, Spain
-
MonTa Biosciences ApSAllucentRecruitingAdvanced Solid TumorBelgium, Denmark, Spain
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
Pierre Fabre MedicamentTerminatedLocally Advanced or Metastatic Solid TumorsFrance, Spain
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
AstraZenecaSyneos HealthCompletedAdvanced Solid TumoursUnited States, Spain, Korea, Republic of, United Kingdom
-
T-knife GmbHTerminatedAdvanced Solid TumorsGermany, Belgium, Spain, Netherlands, United Kingdom
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid TumorsUnited States, Spain, Canada, Norway, Switzerland
-
Genentech, Inc.RecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Korea, Republic of, United States, Brazil, Australia, Argentina, Spain, New Zealand, Poland
-
PharmaMarRecruitingAdvanced Solid TumorBelgium, United States, Spain
-
Vividion Therapeutics, Inc.RecruitingAdvanced Solid TumorsUnited States, Spain
-
AmgenCompletedAdvanced Solid TumorsUnited States, Belgium, Spain, Australia
-
ADC Therapeutics S.A.Active, not recruitingAdvanced Solid TumorsUnited States, Spain, United Kingdom
-
Pyxis Oncology, IncRecruiting
-
Vall d'Hebron Institute of OncologyTaisho Pharmaceutical Co., Ltd.; Roche Pharma AG; Iqvia Pty Ltd; Janssen, LPRecruitingAdvanced Solid TumorSpain, France, Germany, Netherlands, Sweden, United Kingdom, Italy
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid Tumor | Advanced Solid TumorSpain, United States, Netherlands, United Kingdom
-
Immunocore LtdTerminatedSelect Advanced Solid TumorsUnited States, United Kingdom, Spain
-
Puma Biotechnology, Inc.TerminatedSolid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsFrance, United States, Spain, Belgium, United Kingdom, Serbia, Australia, Israel, Canada, Denmark, Ireland, Italy, Korea, Republic of
-
Mural Oncology, IncRecruitingAdvanced Solid TumorUnited States, Spain
-
Oncomatryx Biopharma S.L.RecruitingAdvanced Solid TumorUnited States, Spain
-
Cytovation ASMerck Sharp & Dohme LLCActive, not recruitingAdvanced Solid Tumor MalignancyNetherlands, France, Spain
-
PharmaMarRecruitingAdvanced Solid TumorUnited States, Spain, France
-
AmgenCompletedAdvanced Solid TumorsBelgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom